Does early palliative identification improve the use of palliative care services?


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 10 01 2019
accepted: 29 11 2019
entrez: 1 2 2020
pubmed: 1 2 2020
medline: 9 4 2020
Statut: epublish

Résumé

To evaluate whether the early identification of patients who may benefit from palliative care impacts on the use of palliative, community and acute-based care services. Between 2014 and 2017, physicians from eight sites were encouraged to systematically identify patients who were likely to die within one year and would were thought to benefit from early palliative care. Patients in the INTEGRATE Intervention Group were 1:1 matched to controls selected from provincial healthcare administrative data using propensity score-matching. The use of palliative care, community-based care services (home care, physician home visit, and outpatient opioid use) and acute care (emergency department, hospitalization) was each evaluated within one year after the date of identification. The hazard ratio (HR) in the Intervention Group was calculated for each outcome. Of the 1,185 patients in the Intervention Group, 951 (80.3%) used palliative care services during follow-up, compared to 739 (62.4%) among 1,185 patients in the Control Group [HR of 1.69 (95% CI 1.56 to 1.82)]. The Intervention Group also had higher proportions of patients who used home care [81.4% vs. 55.2%; HR 2.07 (95% CI 1.89 to 2.27)], had physician home visits [35.5% vs. 23.7%; HR 1.63 (95% CI 1.46 to 1.92)] or had increased outpatient opioid use [64.3% vs. 52.1%); HR 1.43 (95% CI 1.30 to 1.57]. The Intervention Group was also more likely to have a hospitalization that was not primarily focused on palliative care (1.42 (95% CI 1.28 to 1.58)) and an unplanned emergency department visit for non-palliative care purpose (1.47 (95% CI 1.32 to 1.64)). Physicians actively identifying patients who would benefit from palliative care resulted in increased use of palliative and community-based care services, but also increased use of acute care services.

Identifiants

pubmed: 32005036
doi: 10.1371/journal.pone.0226597
pii: PONE-D-19-00900
pmc: PMC6994244
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0226597

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: NM, MM, SG, SS are employees. SB, AJ, FW are consultants to CCO. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Pharm Stat. 2011 Mar-Apr;10(2):150-61
pubmed: 20925139
Circulation. 2016 Feb 9;133(6):601-9
pubmed: 26858290
Stat Med. 2009 Nov 10;28(25):3083-107
pubmed: 19757444
J Clin Oncol. 2015 May 1;33(13):1438-45
pubmed: 25800768
BMJ. 2014 Jun 06;348:g3496
pubmed: 24906901
Ann Surg Oncol. 2018 Jun;25(6):1478-1487
pubmed: 29569126
J Clin Oncol. 2017 Mar 10;35(8):834-841
pubmed: 28029308
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
Int J Nurs Stud. 2012 May;49(5):586-95
pubmed: 22130508
Curr Oncol. 2014 Dec;21(6):281-93
pubmed: 25489255
J Clin Oncol. 2015 May 1;33(13):1420-1
pubmed: 25800757
Support Care Cancer. 2018 Sep;26(9):2945-2953
pubmed: 29704108
Stat Med. 2013 Jul 20;32(16):2837-49
pubmed: 23239115
Lancet. 2014 May 17;383(9930):1721-30
pubmed: 24559581
Palliat Med. 2017 Mar;31(3):247-257
pubmed: 27317412
BMJ Support Palliat Care. 2013 Sep;3(3):300-8
pubmed: 24644748
J Clin Oncol. 2014 Sep 10;32(26):2913-9
pubmed: 25113773
BMJ Support Palliat Care. 2014 Sep;4(3):285-90
pubmed: 24644193
CMAJ. 2018 Apr 30;190(17):E525-E531
pubmed: 29712671
Psychooncology. 2018 Dec;27(12):2673-2676
pubmed: 30187984
JAMA. 2009 Aug 19;302(7):741-9
pubmed: 19690306

Auteurs

Nicole Mittmann (N)

Cancer Care Ontario, Toronto, Ontario, Canada.
Sunnybrook Research Institute, Toronto, Ontario, Canada.

Ning Liu (N)

ICES, Toronto, Ontario, Canada.

Marnie MacKinnon (M)

Cancer Care Ontario, Toronto, Ontario, Canada.

Soo Jin Seung (SJ)

Sunnybrook Research Institute, Toronto, Ontario, Canada.
Health Outcomes and PharmacoEconomics (HOPE) Research Centre, Toronto, Ontario, Canada.

Nicole J Look Hong (NJ)

ICES, Toronto, Ontario, Canada.
Odette Cancer Centre, Toronto, Ontario, Canada.

Craig C Earle (CC)

ICES, Toronto, Ontario, Canada.
Odette Cancer Centre, Toronto, Ontario, Canada.
Canadian Partnership Against Cancer, Toronto, Ontario, Canada.

Sharon Gradin (S)

Cancer Care Ontario, Toronto, Ontario, Canada.

Saurabh Sati (S)

Cancer Care Ontario, Toronto, Ontario, Canada.

Sandy Buchman (S)

Temmy Latner Centre for Palliative Care, Sinai Health System, Toronto, Ontario, Canada.

Ahmed Jakda (A)

McMaster University, Hamilton, Ontario, Canada.
Ontario Palliative Care Network, Toronto, Ontario, Canada.
Grand River Regional Cancer Centre, Kitchener, Ontario, Canada.

Frances C Wright (FC)

Odette Cancer Centre, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH